ESC 365 - hsa-miR-548v controls the viscoelastic properties of human cardiomyocytes and improves their relaxation rates.

Delegate Premium access

hsa-miR-548v controls the viscoelastic properties of human cardiomyocytes and improves their relaxation rates.

Session: Novel therapeutic targets in left and right ventricular dysfunction

Topic: Drugs, Drug Targets

Speaker: Professor J. Hulot (Paris, FR)

Event: HFA Winter Research Meeting on Translational Heart Failure 2025

Seminar Presentation

Add to my library

About the speaker

Professor Jean-Sebastien Hulot

PARCC INSERM U970 European Hospital Georges Pompidou APHP, Paris (France)

13 presentations

1 follower

3 more presentations in this session

Targeting EPAC1 in heart failure

Speaker: Doctor F. Lezoualc'h (Toulouse, FR)

Cardioprotective potential of soluble CD39L3 in myocardial infarction

Speaker: Doctor G. Vilahur (Barcelona, ES)

CD69 expression on regulatory T cells protects from immune damage after myocardial infarction

Speaker: Doctor P. Martin (Madrid, ES)

Access the full session

Novel therapeutic targets in left and right ventricular dysfunction

Speakers: Professor J. Hulot, Doctor F. Lezoualc'h, Doctor G. Vilahur, Doctor P. Martin

About the event

HFA Winter Research Meeting on Translational Heart Failure 2025

20 January - 22 January 2025

Seminar

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources